Novel measures for the diagnosis of hepatic steatosis using contrast-enhanced computer tomography images.


Journal

European journal of radiology
ISSN: 1872-7727
Titre abrégé: Eur J Radiol
Pays: Ireland
ID NLM: 8106411

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 17 07 2022
revised: 23 12 2022
accepted: 17 01 2023
pubmed: 2 2 2023
medline: 18 2 2023
entrez: 1 2 2023
Statut: ppublish

Résumé

Hepatic steatosis is often diagnosed non-invasively. Various measures and accompanying diagnostic thresholds based on contrast-enhanced CT and virtual non-contrast images have been proposed. We compare these established criteria to novel and fully automated measures. CT data sets of 197 patients were analyzed. Regions of interest (ROIs) were manually drawn for the liver, spleen, portal vein, and aorta to calculate four established measures of liver-fat. Two novel measures capturing the deviation between the empirical distributions of HU measurements across all voxels within the liver and spleen were calculated. These measures were calculated with both manual ROIs and using fully automated organ segmentations. Agreement between the different measures was evaluated using correlational analysis, as well as their ability to discriminate between fatty and healthy liver. Established and novel measures of fatty liver were at a high level of agreement. Novel methods were statistically indistinguishable from the established ones when taking established diagnostic thresholds or physicians' diagnoses as ground truth and this high performance level persisted for automatically selected ROIs. Automatically generated organ segmentations led to comparable results as manual ROIs, suggesting that the implementation of automated methods can prove to be a valuable tool for incidental diagnosis. Differences in the distribution of HU measurements across voxels between liver and spleen can serve as surrogate markers for the liver-fat-content. Novel measures do not exhibit a measurable disadvantage over established methods based on simpler measures such as across-voxel averages in a population with low incidence of fatty liver.

Identifiants

pubmed: 36724687
pii: S0720-048X(23)00022-0
doi: 10.1016/j.ejrad.2023.110708
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110708

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Sebastian Prinz (S)

Division of Radiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Medical Faculty Heidelberg, Heidelberg University, 69120 Heidelberg, Germany. Electronic address: s.prinz@dkfz-heidelberg.de.

Jacob M Murray (JM)

Division of Radiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Medical Faculty Heidelberg, Heidelberg University, 69120 Heidelberg, Germany; Institute for AI in Medicine (IKIM), University Medicine Essen, 45131 Essen, Germany.

Christian Strack (C)

Division of Radiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Medical Faculty Heidelberg, Heidelberg University, 69120 Heidelberg, Germany.

Johanna Nattenmüller (J)

Department of Diagnostic and Interventional Radiology, Heidelberg University Hospital, 69120 Heidelberg, Germany; Department of Diagnostic and Interventional Radiology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.

Kelsey L Pomykala (KL)

Institute for AI in Medicine (IKIM), University Medicine Essen, 45131 Essen, Germany.

Heinz-Peter Schlemmer (HP)

Division of Radiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Stephanie Badde (S)

Department of Psychology, Tufts University, 02511 Medford, MA, USA.

Jens Kleesiek (J)

Institute for AI in Medicine (IKIM), University Medicine Essen, 45131 Essen, Germany; German Cancer Consortium (DKTK), Partner Sites Heidelberg and Essen, 69120 Heidelberg, Germany; Cancer Research Center Cologne Essen, West German Cancer Center Essen, 45122 Essen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH